32LBA The AGITG ICECREAM Study: The Irinotecan Cetuximab...

32LBA The AGITG ICECREAM Study: The Irinotecan Cetuximab Evaluation and Cetuximab Response Evaluation Amongst Patients with a G13D Mutation – analysis of outcomes in patients with refractory metastatic colorectal cancer harbouring the KRAS G13D mutation

Segelov, E., Thavaneswaran, S., Waring, P., Desai, J., Mann, K., Elez, E., Chantrill, L., Pavlakis, N., Nott, L., Underhill, C., Khasraw, M., Wasan, H., Ciardiello, F., Jefford, M., Joubert, W., Haydo
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(15)30078-2
Date:
September, 2015
File:
PDF, 61 KB
english, 2015
Conversion to is in progress
Conversion to is failed